Shire pleased with Vyvanse growth (4:51)
Nov. 12 - Specialty drug maker Shire says the refill rate for it's Vyvanse drug used to treat ADHD is ''better than 90-percent'' as it enters its 18th week on the market.
Hard-edged reporting, insight and analysis, Reuters TV breaks ground creating informative news and financial videos. Showcasing Reuters’ 3000 award-winning journalists, Reuters TV delivers high-energy investigative journalism with concise explanations. Check it out and let us know what you think.